
This comes after AstraZeneca said it was launching a new fund with China International Capital Corp to invest $1 billion in China's healthcare sector, as it expands its research work in the country.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2pNaR7j
via
IFTTT
0 comments:
Post a Comment